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Abstract
Fumonisin B1 (FB1), a mycotoxin produced by Fusarium moniliforme and related fungi, is nephrotoxic, neurotoxic,
hepatotoxic, carcinogenic and immunosuppressive in animals and man. In this study we evaluate the modifications of
fluidity, endocytosis and peroxidative damage of plasma membrane induced by FB1 in macrophage cell line J774A.1.
In these immune cells FB1 (1–10 M) enhances membrane fluidity and increases, time-dependently, the horseradish
peroxidase (HRP) endocytosis. This effect is concentration-dependent, significant at 10 M, and reverted by IFN-
(100 U/ml). Moreover, FB1 (1–10 M) induces a membrane peroxidative damage as evident by the increase of
malondialdehyde (MDA) production. All these mycotoxin effects provide additional insight into potential mechanism
by which FB1, in macrophages, might enhance membrane damage and oxidative stress contributing to the
pathogenesis of mycotoxin induced diseases. © 2002 Published by Elsevier Science Ireland Ltd.
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1. Introduction
Fusarium moniliforme Sheldon and Fusarium
proliferatum are fungal pathogens which are
prevalent on corn, sorghum, millet, and a number
of other grains grown throughout the world
(Marasas et al., 1984). Most strains of these fungi
produce a variety of mycotoxins of which the
major class are called fumonisins. Several differ-
ent types of fumonisins have been structurally
identified but the total number is not yet known.
The ‘B’ series includes the most prevalent type,
fumonisin B1 (FB1), which is both toxic and car-
cinogenic for animals (Ross et al., 1990; Norred
and Voss, 1994).
The mechanism of fumonisin B1 toxicity is not
fully understood, however, fumonisins are known
to be involved in the complex sphingolipid
metabolism (Wang et al., 1991). In particular the
fumonisins, inhibiting sphinganine N-acyltrans-
ferase, induce an accumulation of sphinganine, an
intermediate in the de novo biosynthesis of sphin-
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golipids, in different tissues and cell types (Merrill
et al., 1993; Badiani et al., 1996; Gelderblom et
al., 1997). Moreover, fumonisins increase the
amounts of free sphingoid bases, with a concomi-
tant reduced synthesis of complex sphingolipids
(Wang et al., 1991; Ramasamy et al., 1995; Riley
et al., 1996).
The sphingolipids are a class of membrane
lipids which play an important role in cell signal
transduction pathways, cell contact, growth, dif-
ferentiation, cell death and the immune response
(Merrill et al., 1997). Considering the important
role of the sphingolipids in the cell, it is likely that
disruption of the de novo sphingolipid biosynthe-
sis would also produce profound effects on cell
membrane structure and function, so most of the
cellular effects and in vivo pathological effects of
fumonisins are likely to be due to a disruption of
sphingolipid metabolism (Riley et al., 1996).
In fact, FB1 disrupts the barrier function of the
endothelial cells doubling the rate of albumin
transfer across the monolayers (Ramasamy et al.,
1995). The effects of the mycotoxin could change
the cell response to external stimuli, modifying the
binding of proteins, receptors or enzymes in-
volved in the different pathways of transduction
signalling.
Although the pathologic and toxic effects of
FB1 are well established, there is very little known
about its effect on the immune cells and in partic-
ular macrophages. The available data on im-
munotoxicity indicate that fumonisin-induced
changes in immune function are not species spe-
cific, and appear to involve aspects of humoral,
cellular and innate immunity (Bondy and Pestka,
2000). In particular both in vitro and in vivo
studies have focused on the effects of FB1 on
morphological and functional alterations of
macrophages (Qureshi and Hagler, 1991; Dugyala
et al., 1998; Meli et al., 2000).
Considering the clear relationship between the
oxidative damage, the structural order of plasma
membrane lipids, the membrane’s ability to inter-
nalise, and the physiological immunocompetent
role of the macrophages, the aim of this study was
to evaluate in a macrophage cell line (J774A.1)
the mycotoxin effects on: (1) the structural organ-
isation of the plasma membrane through a study
of membrane fluidity; (2) the membrane related
functions such as the endocytic activity; and (3)
the production of malondialdehyde, one of the
secondary products of lipid peroxidation.
2. Materials and methods
2.1. Materials
FB1 was obtained by Sigma (Italy), with a 99%
purity ascertained by thin layer chromatography.
Foetal bovine serum (FBS), tissue culture media,
and supplements were purchased from Hy Clone
(UK). Bovine serum albumin, Bio-Rad protein
assay, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl te-
trazolium bromide (MTT), malondialdehyde
(MDA), thiobarbituric acid (TBA), trichloroacetic
acid (TCA), interferon- (IFN-), and 1,6-
diphenyl-1,3,5-hexatriene (DPH) were purchased
from Sigma. Horseradish peroxidase (HRP, 505
U/mg activity) was purchased from Serva (USA).
3,3,5,5 tetramethylbenzidine (TMB) substrate kit
was obtained from Pierce (USA).
2.2. Cell culture
The J774A.1 cell line (BALB/c murine
macrophages) was maintained in a complete
medium (cDMEM) consisting of Dulbecco’s
modified Eagle’s medium supplemented with 4.4%
NaHCO3 (Hy Clone), penicillin (100 U/ml), strep-
tomycin (100 g/ml), 2 mM glutamine, 25 mM
Hepes and 10% foetal calf serum (FCS) (Hy
Clone).
2.3. Cytotoxicity assay
Cells were mechanically scraped, and plated
3×104/well in a 96-well plate to a final volume of
150 l. After 72 h of incubation with FB1, at
increasing concentrations (1, 5, and 10 M), 25 l
of MTT (5 mg/ml) were added to each well and
incubated for 3 h at 37 °C. After incubation, the
cells were lysed with 100 l of lysis buffer (20%
SDS and 50% DMF, pH 4.7) and incubated for
18 h at 37 °C. The optical densities (OD620) of the
samples treated with the different serial dilutions
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of FB1 were compared to the OD of the controls
to obtain a concentration–effect toxicity curve.
Cell survival percentage was calculated as myco-
toxin treated OD/control OD×100 (Mosmann,
1983).
2.4. Membrane preparation and measurement of
membrane microiscosity
The method to prepare cell membranes has
been previously reported (Muccioli et al., 1996)
and opportunely modified. Briefly, after 24 h of
incubation with the different concentrations of
FB1 (1–10 M), J774A.1 cells (about 15×106
cells for every condition) were washed twice in
PBS 1X, collected, and homogenized in 0.3 M
sucrose, 25 mM Tris–HCl. Cell homogenates
were sonicated for 10 min and spun at 8000 rpm
for 20 min at 4 °C. The supernatants were then
centrifuged at 29000 rpm for 60 min at 4 °C. The
pellets were resuspended in 25 mM Tris–HCl, 10
mM MgCl2 and kept at −80 °C until use.
Membrane microviscosity () was evaluated by
fluorescence polarisation () as previously de-
scribed by Shinitzky and Barenholz (1978). The
absorption and emission spectra of DPH in the
J774 membrane suspension were determined. A
sample of the membrane suspension (10 g
protein) was incubated with 2 M of DPH in a
final volume of 1.5 ml assay buffer containing 25
mM Tris–HCl, 10 mM MgCl2, pH 7.4 for 150
min at 37 °C. Fluorescence intensities were mea-
sured with a Perkin–Elmer spectrophotofluorime-
ter, mod. LS-50, with excitation and emission
wavelengths of 359 and 428 nm, respectively (slits
10 nm). The fluorescence measurements were per-
formed at 37 °C, whilst the samples placed in
quartz cuvettes were being continuously stirred.
The degree of fluorescence polarisation () was
calculated using the following equation:
=Ivv−IvhG/Ivv+IvhG
where Ivv and Ivh are the fluorescence intensities
observed with the analysing polariser, respec-
tively, vertical and horizontal to the polarised
excitation beam and G is the correction factor for
the optical system.
Membrane fluidity was expressed as microvis-
cosity calculated by the empirical relation =2/
0.46−. Each assay was carried out in triplicate.
2.5. Endocytosis of HRP and its quantification
In order to evaluate the effect of fumonisin on
the endocytic function, J774A.1 cells were plated
1.5×106 cells/P60 dish and incubated with FB1 at
increasing concentrations (1–10 M) in the pres-
ence or not of IFN- (100 U/ml) for 24 h. The
capacity of J774A.1 to internalise HRP was deter-
mined by incubating the cells at 37 °C with HRP
(1 mg/ml) dissolved in DMEM containing 10%
BSA for 40–80–120 min according to the method
of Noble et al. (Noble et al., 1994). Internalisation
was stopped by transferring the cells to 4 °C and
immediately rinsing in ice-cold 0.5% BSA in
DMEM, followed by four washes of 5 min each in
order to minimise non-cell bound HRP. Finally,
the cells were lysed in lysis buffer (50 mM Tris–
HCl, pH 7.8, 150 mM NaCl, 10 mM EDTA, 1%
TX-100, 0.1% sodium deoxycholate and 1 mM
phenylmethylsulphonylfluoride).
The HRP activity was assayed by the TMB
method according to the manufacturer’s instruc-
tions. A standard curve was prepared using 0–
33.3 ng/ml dissolved in 0.05% TX-100.
Briefly, 10 l of each HRP standard concentra-
tion or the same volume of sample dilutions (in
triplicate) were added to each well of the 96-well
plate. Hundred microlitres of the TMB complete
substrate were then added and incubated until a
brilliant blue colour developed. The reaction was
terminated with 100 l 2 M sulphuric acid and the
absorbance read at 450 nm. The sample content
of HRP was calculated from a linear regression
analysis of the standard curve and expressed as g
of peroxidase/mg of proteins.
2.6. Lipid peroxidation
The determination of cellular lipid peroxidation
was measured by the method previously described
(Draper and Hadley, 1990). Briefly, cells were
plated in P60 dishes (1.5×106/3 ml) and incu-
bated for 24 h in cDMEM in the absence (con-
trol) or in the presence of 1, 5, and 10 M of FB1.
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In another set of experiments IFN- (100 U/ml)
was used in combination with the mycotoxin.
Then cells were collected and lysed and analysis of
the MDA content in the cells was performed by
thiobarbituric acid reactive substances (TBARS)
assay.
MDA standards were prepared by using
1,1,3,3-tetramethoxypropane in PBS. 900 l of
each sample were mixed with 2 ml of 10% TCA,
centrifuged at 3000 rpm for 10 min, followed by
1.3 ml of 0.5% TBA. After 20 min at 100 °C,
fluorescence of the mixture was measured with a
Perkin–Elmer spectrofluorimeter mod. LS-5B at
the wavelengths of 530 and 550 nm, respectively,
for excitation and emission. The MDA quantities
were calculated by linear regression analysis of the
standard curve. Values were expressed as pmol
MDA/mg proteins.
2.7. Protein determination
In the endocytosis studies the protein concen-
tration of the samples was determined by Bio-Rad
protein assay using bovine serum albumin as the
standard. In lipid peroxidation assay, the cell
protein content was determined by the method of
Lowry et al. (Lowry et al., 1951).
2.8. Statistical analysis
Each experiment was repeated three times and
the data subjected to analysis of variance with a
computerised package for statistical analysis.
Comparisons were made using the Bonferroni or,
when appropriate, the Dunnett multiple compari-
son test. A P value 0.05 was considered as
significant.
3. Results
3.1. Effect of FB1 on J774A.1 iability
FB1 at the used concentrations (1, 5, and 10
M) induced a decrease of cell viability. The
mortality percentage values in comparison to un-
treated cells were 6.571.78, 11.301.93,
24.430.81, respectively. This effect was signifi-
cant only at the highest concentration (P0.01).
3.2. Membrane fluidity of J774A.1 cells
We evaluated the membrane microviscosity of
J774A.1 cells inversely related to fluidity. This
parameter directly reflects a modification of the
physical state of the membrane. The lipid struc-
ture of the macrophage membrane was estimated
by steady-state fluorescence polarisation at 37 °C,
using a DPH probe (Fig. 1). As evident FB1
induced a significant reduction of microviscosity
at 10 M (P0.05).
3.3. HRP endocytosis
Endocytosis of HRP was studied in J774A.1
macrophage cells. The amount of internalised
HRP was directly related to the HRP concentra-
tion in the incubation medium, and was time
dependent; moreover endocytosis proceeded at
37 °C but was abolished at 4 °C (data not
shown), so HRP can be considered a tracer of
fluid-phase endocytosis.
As reported in Fig. 2, the increase of HRP
endocytosis (expressed as g HRP/mg cell
protein) induced by a 72 h pre-treatment with FB1
(10 M) was time-dependent and more evident
after 120 min of incubation with the enzyme
(P0.01). At the same incubation time, lower
FB1 concentrations (1 and 5 M) did not modify
significantly HRP endocytosis (Fig. 3). Moreover
IFN- (100 U/ml) alone reduced HRP endocyto-
Fig. 1. Effect of different concentrations of FB1 (1–5 and 10
M) on the microviscosity of J774A.1 membrane subfractions.
Membrane fluidity was expressed as microviscosity calculated
by  (see Section 2). Each value was carried out in triplicate
SEM (*P0.05 vs. control).
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Fig. 2. Fluid phase endocytosis of HRP (1 mg/ml, 40, 80 and
120 min of exposure at 37 °C) by J774A.1 cells after 24 h
incubation with FB1 (10 M). The values are expressed as g
HRP/mg of total protein (*P0.05, **P0.01 vs. respective
controls).
Fig. 4. Effect of FB1 (1–5–10 M) on cultured macrophage
cell peroxidation as measured by the MDA content in the
cellular lysates after 24 h of mycotoxin incubation. The values
for treated-cells peroxidation are expressed as % of peroxida-
tion of control cells and are the meansSEM of three differ-
ent experiments (*P0.05, **P0.01 vs. control).
macrophages with increasing concentrations of
FB1 (1–10 M) generated an increase in the
amount of MDA. This effect was statistically
significant at 5 and 10 M (P0.05 and 0.001,
respectively).
4. Discussion
It has been postulated that cell membranes are
one of the principal targets for fumonisins in
vitro. The findings that the fumonisins are potent
inhibitors of the enzyme sphinganine N-acyltrans-
ferase, and hence of the ceramide synthase in the
endoplasmic reticulum, is one of the possible ex-
planations for their toxicity. Inhibition of ce-
ramide synthase, by fumonisin not only blocks
biosynthesis of complex sphingolipids, but also
causes accumulation of sphingoid bases, which in
turn can alter the plasma membrane composition
and function (Wang et al., 1991; Riley et al., 1996;
Ramasamy et al., 1995).
It is well known that membrane fluidity is a
biophysical property of the membrane which
quantitatively expresses the mobility and the rate
of rotational movement of the lipid molecules in
the membrane. Membrane fluidity appears to
change during development, ageing and exposure
to toxic agents; moreover, modifications in mem-
brane fluidity are known to be linked to alter-
ations in the physiological processes of cell
membrane-mediated transport, activities of mem-
sis (P0.001) performed at 120 min and its effect
was also significant in the presence of FB1 at 10
M (P0.01).
3.4. Lipid peroxidation
Peroxidation of phospholipids generates MDA
and several MDA-like aldehydes and ketones,
which react with TBA (Bird and Draper, 1984).
However, for the purpose of this study, TBA
reactivity will be equated with MDA, since it is
the major reactive product generated. As shown
in Fig. 4, a 24 h treatment of J774A.1
Fig. 3. Endocytosis of HRP (1 mg/ml) after 120 min of
exposure of J774A.1 cells pretreated for 24 h with FB1 (10
M) alone or in combination with INF- (100 /ml). The
values are expressed as % of HRP endocytosis of control cells
lysates and are the meansSEM of three different experi-
ments (**P0.01, ***P0.001 vs. control; c cP0.01 vs.
FB1 alone).
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brane bound enzymes, receptor binding, phagocy-
tosis, endocytosis, cytotoxicity, and cell growth.
The study of steady-state fluorescence was used
to evaluate changes in macrophage membrane
fluidity (Petty et al., 1987). This measurement of
fluorescence polarisation was performed using a
membrane intercalated probe (DPH), an excellent
probe for membrane subfractions. From our stud-
ies in macrophages J774A.1, it is evident that FB1
decreases microviscosity increasing membrane
fluidity.
These observed changes in membrane fluidity
may play a role in controlling fluid-phase endocy-
tosis. In macrophages and fibroblasts HRP is
taken up by fluid-phase endocytosis (Steinman
and Cohn, 1972; Steinman et al., 1974). Fluid-
phase endocytosis involves the uptake of macro-
molecules in an extracellular fluid into
membrane-bound endocytic vesicles (Silverstein et
al., 1977). Neither membrane receptors nor cell
surface adsorption appear to be implicated in this
process and as a result, uptake is concentration
dependent and can be effectively blocked at 4 °C.
Our experiments have confirmed these findings
and demonstrated that the internalisation of HRP
is modified by cell treatment with FB1.
HRP endocytosis was only significantly in-
creased by 10 M FB1 and this effect was more
evident after 120 min of HRP incubation. In our
experiments IFN- alone inhibited the fluid-phase
endocytosis in J774A.1 cells and was able to exert
its effect also in the presence of FB1. These results
are consistent with the findings that IFN- in-
hibits both fluid-phase and receptor-mediated en-
docytosis in mouse peritoneal macrophages
(Konopski et al., 1995; Montaner et al., 1999).
Our study also reports experimental findings
into the way that FB1 alters the function of cell
membranes and lipid packing. The effects of this
mycotoxin on cultured macrophages were as-
sessed by evaluating their cell lipid peroxidation.
One possible intermediate in the mechanism re-
sponsible for peroxidation-induced alteration of
lipid packing is MDA, the principal product of
phospholipid peroxidation. The MDA content in
cellular lysates showing evident lipid peroxidation
is increased concentration-dependently by FB1.
Membrane damage caused by lipid peroxidation
may also contribute towards oxidative damage of
DNA, which has often been implicated in carcino-
genesis (Sahu, 1990).
Our results are consistent with those of previ-
ous papers indicating the multiple effects of the
interactions of the fumonisins with the lipid bilay-
ers; fumonisin alters the complex interrelationship
between the structure of the cell membranes and
their susceptibility to oxidative damage (Yin et
al., 1996b,a). Moreover, fumonisin disturbs mem-
brane structure, promotes the production of inter-
mediate free radicals and accelerates the chain
reaction associated with lipid peroxidation in egg
yolk phosphatidylcholine bilayers (Yin et al.,
1998).
The disruption of membrane structure, the en-
hancement of membrane endocytosis, and the in-
crease in membrane permeability caused by FB1
in macrophages provide additional insight into
potential mechanisms by which the fumonisins
might enhance oxidative stress and cellular
damage.
In conclusion the mechanisms by which FB1
affect the structure and functions of macrophage
cell membranes may contribute to the pathogene-
sis of the diseases caused by this mycotoxin.
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